Abstract
ObjectiveTo assess healthcare workers’ (HCWs) confidence level in diagnosing and managing mpox disease and its associated factors in hospitals in the Amhara Region.DesignInstitution-based cross-sectional study.SettingHospitals in the Amhara Region, Northwest Ethiopia.ParticipantsA total of 640 HCWs, with a response rate of 96.9%, participated from 1 October to 30 December 2022. A multistage stratified random sampling technique with proportional allocation was used to recruit study participants. Data were collected using the KoboCollect toolbox and exported to STATA V.17 for analysis. Descriptive statistics were used to describe data. Ordinal logistic regression analysis was used to identify predictors of confidence level to diagnose and manage mpox at p<0.05.Primary outcomeHCWs’ confidence level in diagnosing and managing mpox disease and its associated factors.ResultsThe overall proportion of HCWs who had high confidence level in diagnosing and managing mpox disease was found to be 31.5% (95% CI: 27.9%, 35.2%). Similarly, 26.8% (95% CI: 23.2%, 30.3%) and 41.8% (95% CI: 38.1%, 45.4%) of HCWs expressed medium and low confidence level to diagnose and manage the disease, respectively. The odds of higher confidence versus lower or medium confidence level in diagnosing and managing mpox were greater for HCWs who regularly visit amenable websites (adjusted OR (AOR)=1.59, 95% CI: 1.16, 2.2), were physicians (AOR=1.9, 95% CI: 1.32, 2.73), were aged 30–35 years old (AOR=1.64, 95% CI: 1.12, 2.39), had got public health emergency epidemic disease management training (AOR=2.8, 95% CI: 1.94, 4.04) and had positive attitudes (AOR=1.72, 95% CI: 1.26, 2.36) compared with their counterparts.ConclusionThe overall confidence level of HCWs in diagnosing and managing mpox disease in the study area was low. Therefore, the HCWs should be regularly updated about mpox disease through morning sessions and training in the diagnosis and clinical management of mpox disease including infection prevention and control.
Reference58 articles.
1. Monkeypox (Mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis;Karagoz;J Infect Public Health,2023
2. A review of the past, present, and future of the Monkeypox virus: challenges, opportunities, and lessons from COVID-19 for global health security;Hirani;Microorganisms,2023
3. Perramon A . Analysis of the Epidemiological dynamic of Monkeypox from 15th may to 31st August 2022. 2022;160. Available: www.enfermedadesemergentes.com
4. Global outbreak of human Monkeypox in 2022: update of epidemiology;Ilic;Trop Med Infect Dis,2022
5. Monkeypox between Dermatology and anthropology: A model for evolutionary medicine;Galassi;Clin Dermatol,2023